CJC-1295 (no DAC)
C152H252N44O423367.97 g/mol
$49.00
$9.80 per mg
A stabilised 29-residue GHRH analogue without the drug affinity complex.
Buy more, save more
Applies to any mix of sizes of this compound. Discount shows in your cart.
- Batch RP-CJC-2610, lab report sent on request
- Sealed vial, discreet unbranded packaging
- Order now and it ships on Monday
For in-vitro laboratory research only. Not for human or veterinary use.
Structure
- Hydrophobic
- Polar
- Acidic
- Basic
- Modified / non-standard
Specifications
| Also known as | Modified GRF (1-29), Mod GRF 1-29 |
|---|---|
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ C-terminal amide |
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.97 g/mol |
| Purity specification | ≥98.0% (HPLC) |
| Form | Lyophilized powder, 3 mL glass vial |
| Storage | −20 °C, sealed, protected from light |
Stock solution calculator
Work out the concentration of an in-vitro stock solution from the vial contents and the solvent volume, using this compound’s molecular weight.
- Mass concentration
- –
- Molar concentration
- –
- Amount of substance
- –
Uses MW 3367.97 g/mol and gross fill weight. For quantitative work, correct for net peptide content.
Batch history
Every batch we have released for this compound, with the report for each. Older reports stay available so you can compare lots.
-
RP-CJC-2610 Shipping now
Request report
Research overview
Also called modified GRF (1-29), this is a 29-residue analogue of growth hormone–releasing hormone carrying four substitutions (D-Ala², Gln⁸, Ala¹⁵ and Leu²⁷) that improve resistance to enzymatic degradation and oxidation compared with the native GHRH(1-29) fragment.
This version does not include the drug affinity complex (DAC), the maleimide linker that lets CJC-1295 bind serum albumin. It is used to study GHRH-receptor signalling in the pituitary.



